Biotech Values

[masterlongevity]

having elan look for acquisitions is scary. they have already proven how inept they are in divulging assets at low prices, and how inept they are at drug development.

there is no way they can compete with big pharma and big biotech in finding attractive compounds or companies.

Right now, it is just a holding company, shelling out tons of dollars and options to a large number of unproductive executives